Will China have more phase 3 drug trials than the United States in year X?
One-OffSanté et médecineChine4aManifold MarketsSans KYCDonnées de résolution vérifiéesBien calibréPrévision communautaire actuelle2030 69.2%En tête parmi 5 options
Prévisionnistes
3
Type de question
multiple choice
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Variation 7j
0.0 pts
Données du marché
Mis à jour il y a 11 heures
Obsolète13 juin 26, 23:07 UTC31 déc. 30, 23:59 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Will there be a ban on Chinese biotech trials by US-based companies by EOY2027?
Manifold MarketsWill a majority government owned company introduce a new GLP-1 drug before 2040?
Manifold MarketsEU adopts Chinese telecom gear phase-out law by which date?
PolymarketFDA decision: Ivonescimab by Summit Therapeutics (in 2026)
KalshiWill WW3 start before gta6?
Manifold MarketsWill Ice Cream turn out to actually be "healthy" based on consensus view at EOY 2026?
Manifold MarketsRègles
Resolution criteria
- This is an independent multiple-choice market.
- Each year will resolve independently as YES or NO based on whether China registers more Phase 3 clinical trials than the United States during that calendar year.
- Primary Source of Truth: The database compiled by the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), specifically accessed via the WHO Global Observatory on Health Research and Development dashboard for "Number of clinical trial registrations by year, location, disease and phase of development".
- Resolution Rules:
- YES: If the final count of Phase 3 clinical trial registrations for China (as the trial location) is strictly greater than the count for the United States (as the trial location) for the given calendar year.